官方服务：
资源简介：
AD, Alzheimer's disease; NC, normal control; Tg, transgenic mouse model.
应用场景：
创建时间：
2011-09-30
相关数据集
Data_Sheet_1_Optimal Combinations of AT(N) Biomarkers to Determine Longitudinal Cognition in the Alzheimer's Disease.docx
Background: National Institute on Aging—Alzheimer's Association (NIA-AA) proposed the AT(N) system based on β-amyloid deposition, pathologic tau, and neurodegeneration, which considered the definition
NIAID Data Ecosystem110
Table_1.PDF
The accumulation of amyloid plaques is one of the earliest pathological changes in Alzheimer’s disease (AD) and may occur 20 years before the onset of symptoms. Examining associations between amyloid
NIAID Data Ecosystem50
Data_Sheet_1_Top-Down Proteomics of Human Saliva Highlights Anti-inflammatory, Antioxidant, and Antimicrobial Defense Responses in Alzheimer Disease.pdf
Alzheimer disease (AD) is the most prevalent neurodegenerative disease in the elderly, characterized by accumulation in the brain of misfolded proteins, inflammation, and oxidative damage leading to n
NIAID Data Ecosystem30
A microRNA signature for early detection and RNA therapy in Alzheimer´s disease (miR-148a-3p). A microRNA signature for early detection and RNA therapy in Alzheimer´s disease (miR-148a-3p)
Since changes in cognitive function develop slowly over time, Alzheimer’s disease patients are often diagnosed at an advanced stage of molecular pathology, a time point when causative treatments fail.
NIAID Data Ecosystem90
Associations between plasma amyloid-ß levels and IgM antibodies to herpes simplex virus in the main study sample (n = 1222).
Model 1 adjusted for study center, age, gender and educational level.*Model 1 plus additional adjustment for apolipoprotein E-e4 polymorphism.
Figshare2015-12-02 更新30
